Abstract:OBJECTIVE:The present study aimed to investigate the effectiveness of atosiban in treating women with threatened preterm labor who had become pregnant through assisted reproductive technology (ART) and the corresponding pregnancy outcomes. PATIENTS AND METHODS:Seventy pregnant women with threatened preterm labor after ART were randomly divided into two groups, with 35 cases in the atosiban group and 35 in the ritodrine group. The post-treatment effects and the corresponding pregnancy outcomes were observed. RESULTS:The efficacy of extending gestational age by 48 hours was significantly higher in the atosiban group than in the ritodrine group (p<0.05), whereas the efficacy of extending gestational age by seven days was the same in the two groups (p>0.05). There was no significant difference between the atosiban and ritodrine groups in the average gestational age at birth (p<0.05). The occurrence of side effects in the pregnant women was higher in the ritodrine group than in the atosiban group (p<0.05), although the prevalence of abnormal fetal heart rate was not significantly different (p>0.05). Both the perinatal mortality rate and the prevalence of neonatal asphyxia were significantly lower in the atosiban group than in the ritodrine group (p<0.05). When the medication was applied at a gestational age of fewer than 28 weeks, the perinatal mortality rate and the prevalence of neonatal pneumonia were significantly lower in the atosiban group compared with the ritodrine group (p<0.05). When the first drug administration was at a gestational age of 28 weeks or later, the need for neonatal pediatric treatment was significantly reduced in the atosiban group relative to the ritodrine group. Independent of when the drug administration was initiated, there were no significant differences between the atosiban and ritodrine groups in the occurrences of neonatal asphyxia, acute respiratory distress syndrome (ARDS), neonatal brain injury, or neonatal sepsis (p>0.05). CONCLUSIONS:Administration of atosiban has a comparatively better effect than that of ritodrine on pregnant women who underwent ART and is safe and effective at preventing immediate preterm birth. Atosiban is significantly better than ritodrine at reducing the rates of perinatal mortality and neonatal pneumonia, and the perinatal outcomes for those who began to use atosiban at a gestational age of fewer than 28 weeks were even better.

Atosiban-induced Acute Pulmonary Edema: A Rare but Severe Complication of Tocolysis

Non-Cardiogenic Pulmonary Edema Due to Administration of Atosiban

The Intraoperative Median Effective Dose of Oxytocin for Preventing Uterine Atony in Parturients with a Prior History of Caesarean Delivery

Acute Pulmonary Edema During a Cesarean Delivery After an Adverse Drug Event

Intrapartum Atosiban Treatment During Tachysystole and Non-reassuring Fetal Monitoring: A Retrospective Cohort Study

Intraoperative Acute Pulmonary Embolism: Risk Factors, Diagnosis and Treatment

Clinical Analysis of Tocolysis with Ritodrine Hydrochloride or Atosibanin Treatment of Threatened Preterm Labour

Atosiban for Threatened Premature Labor: A Systematic Review

Acute Pulmonary Embolism in a Patient with Cesarean Scar Pregnancy after Receiving Uterine Artery Embolization: a Case Report

Oxidative Stress in Women Treated with Atosiban for Impending Preterm Birth

[Clinical Experience of Using Oxytocin Antagonist Atosiban in the Rescue Therapy of Preterm Labour].

Evaluation of the Efficacy of Atosiban in Pregnant Women with Threatened Preterm Labor Associated with Assisted Reproductive Technology.

Atosiban Combined with Ritodrine for Late Threatened Abortion or Threatened Premature Labor Patients with No Response to Ritodrine: A Clinical Trial.

Ovarian hyperstimulation syndrome and pulmonary edema – a rare complication

The Impact of Atosiban on Pregnancy Outcomes in Women Undergoing in Vitro Fertilization-Embryo Transfer: A Meta-Analysis.

Successful pulmonary embolectomy for massive pulmonary embolism during pregnancy: a case report

Spontaneous Spinal Epidural Hematoma Complicated by Pulmonary Embolism During Pregnancy: A Case Report

Thrombotic pulmonary embolism of inferior vena cava during caesarean section: A case report and review of the literature

Sudden Respiratory and Circulatory Collapse after Cesarean Section: Amniotic Fluid Embolism or Other Reasons? - a Case Report.

Successful Treatment of Massive Pulmonary Embolism in Pregnancy with Catheter-Directed Embolectomy

Effect of atosiban on in vitro fertilization pregnancy outcome among women with endometriosis in presence or absence of adenomyosis